Stock 2E40 PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus PHAXIAM Therapeutics S.A. Deutsche Boerse AG

Equities

2E40

FR001400K4B1

Delayed Deutsche Boerse AG
Other stock markets
 03:50:03 2024-07-16 pm EDT 		5-day change 1st Jan Change
1.898 EUR -1.15% Intraday chart for PHAXIAM Therapeutics S.A. +0.42% -57.35%
Jul. 03 Phaxiam: EPIC Bpifrance exceeds 25% of share capital CF
Jun. 28 Would you like some more inflation? Our Logo

Evolution of the average Target Price on PHAXIAM Therapeutics S.A.

Price target over the last 5 years

History of analyst recommendation changes

dfe404553d21d209dbe.8vBF0RMlTURjDxi3nvHNt6o8oOU_PBAJ_BwrkAI6YXQ.vKgrpXtRIh4JZUvkytyU8N502ZJwRXk9lFtv0kVyFibFknLgQ055cTBmIA~2a04c1b0a61569c22a7dfbb9c9e456a0

Analyst Recommendations on PHAXIAM Therapeutics S.A.

Phaxiam: EPIC Bpifrance exceeds 25% of share capital CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.998 EUR
Average target price
5.1 EUR
Spread / Average Target
+155.26%
High Price Target
5.3 EUR
Spread / Highest target
+165.27%
Low Price Target
4.9 EUR
Spread / Lowest Target
+145.25%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. 2E40 Stock
  5. Consensus PHAXIAM Therapeutics S.A.